Records containing: Schizophrenia
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2014-02-07Epidemiology Study to Assess the Safety of a New Slow-release Form of Seroquel (Quetiapine) in the Post-marketing Phase in the UK
-
CLINICAL_TRIALS study record update · 2014-02-07Interventions to Test the Alpha7 Nicotinic Receptor Model in Schizophrenia
-
CLINICAL_TRIALS study record update · 2014-02-06An Open-label Prospective Trial to Evaluate the Tolerability, Safety and Maintained Efficacy of a Transition to Paliperidone ER in Subjects With Schizophrenia Previously Unsuccessfully Treated With Other Oral Antipsychotics
-
CLINICAL_TRIALS study record update · 2014-02-06A Phase IIa, Randomized, Multicenter, Double-Blind, Active Comparator- and Placebo-Controlled, Clinical Trial to Study the Safety and Efficacy of MK8998 in Acutely Psychotic Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2014-02-03Prevalence of Dissociative Disorders in Children in a Population Supported in the Medico-social and Health Structures in Provence Alpes Cote d'Azur
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2014-01-31An Open-Label Observational Pilot Study to Evaluate the Pharmacokinetics of Aripiprazole in Subjects With Bipolar 1 Disorder or Schizophrenia Who Have a History of Suboptimal Adherence and Are Currently on Treatment With Oral Aripiprazole
-
CLINICAL_TRIALS study record update · 2014-01-28Objective Assessment of Metabolic Monitoring in Patients Treated With Seroquel® or Seroquel® XR/Quetiapine Fumarate: Use of IMS Disease Analyzer to Assess Physician Behaviour in the UK and Germany
-
CLINICAL_TRIALS study record update · 2014-01-28Assessment of Physician Behavior Regarding Metabolic Monitoring of Patients Treated With SEROQUEL® (Quetiapine Fumarate) Tablets and SEROQUEL® (Quetiapine Fumarate) Extended Release Tablets in Selected Countries in the EU
-
CLINICAL_TRIALS study record update · 2014-01-22An Open-label Parallel Arm Multiple Dose Tolerability, Pharmacokinetics and Safety Study in Adult Patients With Schizophrenia Following Administration of Aripiprazole IM Depot Formulation Once Every Four Weeks
-
CLINICAL_TRIALS study record update · 2014-01-20Phase 4 Study of Efficacy and Safety of Tandospirone Combined With Atypical Antipsychotic Drugs to Improve Cognitive Function in Schizophrenia
-
CLINICAL_TRIALS study record update · 2014-01-17Symptomatic Remission and Social Function in Patients Treated With Paliperidone ER
-
CLINICAL_TRIALS study record update · 2014-01-16Open-label Study to Assess Hospitalization Rates in Adult Schizophrenic Patients Treated With Oral Antipsychotics for 6 Months and IM Depot Aripiprazole for 6 Months, Respectively, in a Naturalistic Community Setting, Europe, Canada and Asia
-
CLINICAL_TRIALS study record update · 2014-01-14An Open Label, Prospective, Non-Comparative Study to Evaluate Flexible Dose of Paliperidone ER and Clinical Response in the Treatment of Subjects With Schizophrenia
-
CLINICAL_TRIALS study record update · 2014-01-13Investigation of Body Mass Index, Body Composition, Resting Energy Expenditure, Respiratory Quotient and Metabolic Changes Following a Switch From Olanzapine, Quetiapine or Risperidone to Aripiprazole
-
CLINICAL_TRIALS study record update · 2014-01-10Aripiprazole (BMS-337039) for Outpatients With Schizophrenia Completing Aripiprazole Clinical Trials: A Non-Comparative Rollover Protocol
-
CLINICAL_TRIALS study record update · 2014-01-06A 6-Month, Open-Label, Single-Arm Safety Study of Flexibly Dosed Paliperidone Extended Release (1.5 - 12 mg/Day) in the Treatment of Adolescents (12 to 17 Years of Age) With Schizophrenia
-
CLINICAL_TRIALS study record update · 2013-12-31Treatment With Ziprasidone for Schizophrenia Patients With Obsessive Compulsive Disorder (OCD)
-
CLINICAL_TRIALS study record update · 2013-12-23Efficacy of Olanzapine in Improving Task Engagement in Schizophrenia
-
CLINICAL_TRIALS study record update · 2013-12-20CSP #555 - Long-Acting Injectable Risperidone in the Treatment of Schizophrenia
-
CLINICAL_TRIALS study record update · 2013-12-20Will Decreased Noradrenergic Activity Normalize Information Processing in Patients With Schizophrenia?
-
CLINICAL_TRIALS study record update · 2013-12-17Adjunctive Aripiprazole in the Treatment of Risperidone-Induced Hyperprolactinemia: A Randomized, Double-Blind, Placebo-Controlled, Dose-Response Study
-
CLINICAL_TRIALS study record update · 2013-12-16Transcranial Direct Current Stimulation (tDCS) as Therapeutical Strategy for Negative Symptoms in Schizophrenia: a Double-blind Randomized Clinical Trial
-
CLINICAL_TRIALS study record update · 2013-12-11Cognitive Training for Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2013-12-10D-serine Antipsychotic Monotherapy for Treatment Refractory Schizophrenia
-
CLINICAL_TRIALS study record update · 2013-12-05Addition of Both Pregnenolone and L-theanine to Ongoing Antipsychotic Treatment for Schizophrenia and Schizoaffective Disorders: an 8-week, Randomized, Double-blind, Placebo-controlled Multicenter Study